Wenjie Xu, MD
Clinical Cardiac Electrophysiology · Baton Rouge, LANPI 1205084076
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,101 of the $10,314 with a category attached, or 78.5%. 36 manufacturers reported payments, led by Medtronic at 36.4% of the total. Reporting peaked in 2024 at $3,737 and has fallen 66.5% since, to $1,253 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in LA, where the typical reported total is $18,132.
Across 334 payments — averaging $30.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abbott$3K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$634
- Johnson & Johnson$530
- Pfizer$422
- Novartis$323
- plus $2K from 30 others
What the payments were for
- Travel & lodging$2,19621%
- Food & beverage$8,10179%
- Other$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 78 | $3,751 |
| Abbott | 42 | $2,649 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 40 | $634 |
| Johnson & Johnson(2 entities) | 39 | $530 |
| Pfizer | 24 | $422 |
| Novartis | 23 | $323 |
| Biotronik Inc. | 8 | $238 |
| Biosense Webster, Inc. | 6 | $217 |
| Amgen | 10 | $189 |
| Irhythm Technologies, Inc. | 8 | $165 |
| Edwards Lifesciences | 4 | $123 |
| E.r. Squibb & Sons, L.L.C. | 7 | $112 |
| Kestra Medical Technology Services, Inc. | 5 | $111 |
| Cardiva Medical, Inc. | 5 | $107 |
| Abiomed | 2 | $88 |
| Baxter Healthcare | 3 | $85 |
| Atricure, Inc. | 3 | $68 |
| Boehringer Ingelheim | 3 | $56 |
| Inspire Medical Systems, Inc. | 1 | $49 |
| Sanofi-aventis U.S. LLC | 3 | $44 |
| AstraZeneca | 3 | $37 |
| Amarin Pharma, Inc. | 2 | $33 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Shockwave Medical, Inc | 1 | $27 |
| Cleerly, Inc. | 1 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Livanova USA, Inc. | 1 | $24 |
| Cordis US CORP. | 1 | $20 |
| Impulse Dynamics (USA) Inc. | 1 | $20 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $19 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $18 |
| Boston Scientific | 1 | $18 |
| Lundbeck LLC | 1 | $15 |
| Novo Nordisk | 1 | $14 |
| Vital Connect, Inc | 1 | $14 |
| Acutus Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PulseSelect$1,224
- AVEIR$1,205
- Carto 3$120
- Achieve$118
- Reveal LINQ$101
How this compares
$10,314 in reported general payments places this provider in the 30th percentile of 43 clinical cardiac electrophysiology providers in Louisiana.
See all clinical cardiac electrophysiology providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 225 | $217,720 |
| XareltoRivaroxaban | 38 | $37,723 |
| EntrestoSacubitril/Valsartan | 23 | $30,977 |
| Metoprolol Succinate | 305 | $4,136 |
| Amiodarone Hcl | 80 | $1,702 |
| Flecainide Acetate | 41 | $1,193 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 41 | $790 |
| Bumetanide | 15 | $653 |
| Atorvastatin Calcium | 47 | $517 |
| Amlodipine Besylate | 78 | $325 |
| Furosemide | 76 | $317 |
| Losartan Potassium | 31 | $241 |
| Cephalexin | 60 | $195 |
| Spironolactone | 14 | $175 |
| Doxazosin Mesylate | 24 | $172 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $422 | $217,720225 claims |
| Johnson & JohnsonXarelto | $530 | $37,72338 claims |
| NovartisEntresto | $323 | $30,97723 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 43 clinical cardiac electrophysiology providers in Louisiana.
Other clinical cardiac electrophysiology in Baton Rouge
- Mark PolletBaton Rouge$90K
- Joshua AymondBaton Rouge$64K
- Thomas GullattBaton Rouge$31K
- Kenneth CivelloBaton Rouge$30K
- Charles SmithBaton Rouge$29K
- Robert DrennanBaton Rouge$18K
- Paul DampfBaton Rouge$12K
- Norman DeumiteBaton Rouge$9K
- Henry PatrickBaton Rouge$4K
- Nassir MarroucheNew Orleans$498K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.